(Q45014752)

8 December 2017

Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours (English)

1 reference

8 December 2017

0 references

Zámecník J

1

1 reference

8 December 2017

Vargová L

2

1 reference

8 December 2017

Homola A

3

1 reference

8 December 2017

Kodet R

4

1 reference

8 December 2017

Syková E

5

1 reference

8 December 2017

language of work or name

1 reference

1 August 2004

1 reference

Neuropathology and Applied Neurobiology

8 December 2017

1 reference

8 December 2017

30

1 reference

8 December 2017

4

1 reference

8 December 2017

338-350

1 reference

Cell-extracellular matrix interaction in glioma invasion

8 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Extracellular space diffusion and pathological states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Glial diffusion barriers during aging and pathological states

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Extracellular space structure revealed by diffusion analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Diffusion barriers evoked in the rat cortex by reactive astrogliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Diffusion parameters of the extracellular space in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Diffusion constraints and neuron-glia interaction during aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

The extracellular matrix of gliomas: modulation of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Extracellular space parameters in the rat neocortex and subcortical white matter during postnatal development determined by diffusion analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

The extracellular space in brain tumours. II. The sucrose space.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Migration and invasion in brain neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Matrix metalloproteinases and their biological function in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Collagens, integrins and the mesenchymal drift in glioblastomas: A comparison of biopsy specimens, spheroid and early monolayer cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Immunohistochemical localisation of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Laminin expression by glial fibrillary acidic protein positive cells in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Immunohistochemical investigation of collagen subtypes in human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Collagen of articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

The structure and function of tenascins in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Clinical impact and functional aspects of tenascin-C expression during glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Localised delivery of therapeutic agents to CNS malignancies: old and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0305-1846.2003.00541.X

10.1046/J.0305-1846.2003.00541.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference